1-4 of 4
Erica Winter
Close
Sort by
Journal Articles

Exposure-Response Relationship of the SMART-Ig Anti-hC5 Antibody Crovalimab (SKY59): Results from the Umbrella Phase 1/2 Composer Trial in Healthy Volunteers and PNH Patients

Alexandre Sostelly, M.Eng., PhD, Simon Buatois, Antoine Soubret, Erica Winter, PharmD, Barbara Klughammer, PhD, Joy C. Hsu, Gregor Jordan, Christoph Bucher, MD, Jean-Eric Charoin, Keisuke Gotanda, Kenji Shinomiya, Zsolt Nagy, MD PhD, Jens P. Panse, Sung-Soo Yoon, MD PhD, Régis Peffault de Latour, MD PhD, Junichi Nishimura, MD PhD, Alexander Röth, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3745.
https://doi.org/10.1182/blood-2019-124258
Published: 2019
Journal Articles

The SMART Anti-hC5 Antibody (SKY59/RO7112689) Shows Good Safety and Efficacy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Alexander Röth, MD, Miklos Egyed, MD PhD, Satochi Ichikawa, MD, Jin Seok Kim, MD PhD, Zsolt Nagy, MD PhD, Julia Gaàl Weisinger, Jens P. Panse, MD, Regis Peffault De Latour, Flore Sicre De Fontbrune, MD PhD, Simona Sica, MD, Kensuke Usuki, MD PhD, Sung-Soo Yoon, MD PhD, Erica Winter, PharmD, Joy C. Hsu, Andreas Dieckmann, Judith Anzures-Cabrera, Gregor Jordan, Kenji Shinomiya, Barbara Klughammer, PhD, Christoph Bucher, MD, Angelika Jahreis, MD PhD, Jun-Ichi Nishimura, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 535.
https://doi.org/10.1182/blood-2018-99-113274
Published: 2018
Journal Articles

Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia

Ali Taher, MD PhD, Vip Viprakasit, MD DPhil, Maria Domenica Cappellini, MD, Dominik Kraus, PhD, Patrick Cech, PhD, Volz Dietmar, PhD, Erica Winter, PharmD, Norman Alan Mazer, MD PhD, Stephane Nave, MD, Juergen Dukart, PhD, Franziska Schaedeli Stark, PhD, Annette Koerner, PhD, Omar Khwaja, MD PhD, Ricardo Hermosilla, DVM, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3635.
https://doi.org/10.1182/blood-2018-99-114776
Published: 2018
Journal Articles

The SMART-IgG Anti-hC5 Antibody (SKY59/RO7112689) Has Favorable PK, PD, Subcutaneous Bioavailability, and Safety Profile in Phase I HV Study

Alexander Roeth, MD, Nagy Zsolt, MD PhD, Miklos Egyed, MD, Erica Winter, Joy Hsu, Andreas Dieckmann, Judith Anzures-Cabrera, Marie Mannino, Elana Fernandez, PhD, Gregor Jordan, Barbara Klughammer, PhD, Kenji Shinomiya, Naoki Kotani, Ido Paz-Priel, MD, Angelika Jahreis., MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4750.
https://doi.org/10.1182/blood.V130.Suppl_1.4750.4750
Published: 2017